Showing results (421-430 of 554) with videos related to
Sort By:
Pageof 56
Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.Plos Medicine|November 18, 2015
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaAngelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, et al.JCI Insight|January 11, 2021
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022Caroline Atyeo, Matthew D Slein, Stephanie Fischinger, et al.Cell|June 18, 2019
Fc Glycan-Mediated Regulation of Placental Antibody TransferMadeleine F Jennewein, Ilona Goldfarb, Sepideh Dolatshahi, et al.Immunity|August 14, 2020
Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalCaroline Atyeo, Stephanie Fischinger, Tomer Zohar, et al.Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccineWilbur H Chen, Robin S Barnes, Michael J Sikorski, et al.Nature Medicine|October 5, 2010
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATFMichael Quigley, Florencia Pereyra, Björn Nilsson, et al.The Lancet. HIV|October 6, 2023
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trialMagdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, et al.Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.Pageof 56